Author Archive
Dynavax says FDA rejects its hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's marketing application for its hepatitis B vaccine, Heplisav-B, for the second time in three years, sending the company's shares tumbling 71 percent in premarket
Nigeria probes new reports of food aid stolen from refugees
YOLA, Nigeria (AP) — Lawmakers in northeastern Nigeria are investigating new allegations that officials have diverted crucial food aid intended for people who have fled from Boko Haram extremists.
AbbVie’s hepatitis C treatment shows promise
(Reuters) - Drugmaker AbbVie Inc said on Friday its experimental fixed-dose combination to treat certain hepatitis C virus patients achieved high sustained viral response (SVR) rates after eight weeks of treatment. The once-daily fixed-dose combination, glecaprevir/pibrentasvir (G/P),
Mosul families squat in squalor between frontline and camps
By John Davison SHAHREZAD, Iraq (Reuters) - At the small mosque in Shahrezad village, piles of human faeces dot the toilets and rubbish is strewn around the garden. Fifty people are crammed into an abandoned and bombed-out
Audi CEO to face renewed VW emissions inquiry: sources
Audi Chief Executive Rupert Stadler will again be questioned by U.S. law firm Jones Day on a reported discovery of a new cheat software device at the luxury car brand, two people familiar with the matter
UK urged to stop locking up stateless "ghost people"
By Emma Batha LONDON (Thomson Reuters Foundation) - Britain is locking up stateless people for long periods even though there is nowhere they can be deported to, campaigners, lawyers and academics said on Thursday as they called
India’s move to curb "black money" will break backbone of traffickers: Satyarthi
By Nita Bhalla NEW DELHI (Thomson Reuters Foundation) - Nobel laureate Kailash Satyarthi has welcomed India's overnight move to withdraw 500 and 1,000 rupee notes from circulation to crack down on corruption and counterfeit currency, saying it
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) - U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14
Study links low vitamin D levels to increased bladder cancer risk
Researchers based in the UK have linked low vitamin D levels to increased risk of bladder cancer. Previous research has highlighted the importance of vitamin D in reducing the risk of cardiovascular disease, cognitive impairment, autoimmune